Generic industry raises issues with FDA’s cover letter checklists
Regulatory NewsMichael Mezher
Health Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory NewsMichael MezherHealth Authority meeting and communication strategyNorth AmericaPharmaceuticals